EVALUATION AND ESTIMATION OF POTENTIAL CARCINOGENIC RISKS OF POLYNUCLEAR AROMATIC HYDROCARBONS (PAH)
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
The evaluation and estimation of the potential risk of human exposures to a hazardous substance requires the analysis of all relevant data to answer two questions (1) does the agent cause the effect; (2) what is the relationship between dose (exposure) and incidence of the effect in humans? or polynuclear aromatic hydrocarbonS (PAH), carcinogenicity is the effect of concern. hree types of evidence can be used to evaluate the likelihood that a PAH is carcinogenic to humans. hey are (1) epidemiologic evidence, (2) experimental evidence derived from long-term animal bioassays, (3) supportive or suggestive evidence from short-term tests, metabolism, pharmacokinetics and structure-activity correlations. athematical modeling can be used to estimate the potential human risks. he approaches and the problems associated with these approaches for estimating cancer risk to humans are addressed with special emphasis on problems related to PAH.
Citation
Chu, M. AND C. Chen. EVALUATION AND ESTIMATION OF POTENTIAL CARCINOGENIC RISKS OF POLYNUCLEAR AROMATIC HYDROCARBONS (PAH). U.S. Environmental Protection Agency, Washington, D.C., EPA/600/D-89/049 (NTIS PB89221329).
Additional Information
Presented at the 1984 International Chemical Congress of Pacific Basin Societies